[go: up one dir, main page]

GB0711234D0 - Urocanic acid derivatives - Google Patents

Urocanic acid derivatives

Info

Publication number
GB0711234D0
GB0711234D0 GBGB0711234.5A GB0711234A GB0711234D0 GB 0711234 D0 GB0711234 D0 GB 0711234D0 GB 0711234 A GB0711234 A GB 0711234A GB 0711234 D0 GB0711234 D0 GB 0711234D0
Authority
GB
United Kingdom
Prior art keywords
acid derivatives
urocanic acid
urocanic
derivatives
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0711234.5A
Other versions
GB2437429A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VALLETTA HEALTH BV
Original Assignee
VALLETTA HEALTH BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VALLETTA HEALTH BV filed Critical VALLETTA HEALTH BV
Priority to GB0711234A priority Critical patent/GB2437429A/en
Publication of GB0711234D0 publication Critical patent/GB0711234D0/en
Publication of GB2437429A publication Critical patent/GB2437429A/en
Priority to EP08766790A priority patent/EP2167474A1/en
Priority to PCT/NL2008/050367 priority patent/WO2008153385A1/en
Priority to US12/664,072 priority patent/US20100197752A1/en
Priority to JP2010512097A priority patent/JP2010529189A/en
Priority to MX2009013599A priority patent/MX2009013599A/en
Priority to AU2008262664A priority patent/AU2008262664A1/en
Priority to KR1020097017057A priority patent/KR20100028016A/en
Priority to CN200880005492A priority patent/CN101679293A/en
Priority to CA2690485A priority patent/CA2690485A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0711234A 2007-06-11 2007-06-11 Urocanic acid derivatives Withdrawn GB2437429A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB0711234A GB2437429A (en) 2007-06-11 2007-06-11 Urocanic acid derivatives
CA2690485A CA2690485A1 (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
CN200880005492A CN101679293A (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
US12/664,072 US20100197752A1 (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
PCT/NL2008/050367 WO2008153385A1 (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
EP08766790A EP2167474A1 (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
JP2010512097A JP2010529189A (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful in the treatment of immune related and inflammatory diseases
MX2009013599A MX2009013599A (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases.
AU2008262664A AU2008262664A1 (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
KR1020097017057A KR20100028016A (en) 2007-06-11 2008-06-11 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0711234A GB2437429A (en) 2007-06-11 2007-06-11 Urocanic acid derivatives

Publications (2)

Publication Number Publication Date
GB0711234D0 true GB0711234D0 (en) 2007-07-18
GB2437429A GB2437429A (en) 2007-10-24

Family

ID=38319146

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0711234A Withdrawn GB2437429A (en) 2007-06-11 2007-06-11 Urocanic acid derivatives

Country Status (1)

Country Link
GB (1) GB2437429A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7993630B2 (en) 2007-02-17 2011-08-09 Bioderm Research Protection of skin from UV and peroxide
CN101397274B (en) * 2008-10-22 2012-06-27 江苏先声药物研究有限公司 Novel natural imidazole formic acid derivates, preparation method and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515789A (en) * 1967-07-17 1970-06-02 Hope City Analgesic-hypnotic therapy with 4-imidazoleacetic acid
JPS5231021B2 (en) * 1972-08-17 1977-08-12
DE3106150A1 (en) * 1981-02-13 1982-09-16 Schering Ag, 1000 Berlin Und 4619 Bergkamen "METHOD FOR PRODUCING IMIDAZOLIC ACID DERIVATIVES"
FR2579461B1 (en) * 1985-03-28 1988-08-26 Strasbourg Universite L Pasteu AMIDES OF PARA-METHOXYCINNAMIC ACID AND UROCANIC ACID FOR USE AS SOLAR FILTERS; PROCESSES FOR OBTAINING, DERMO-PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM AND APPLICATIONS
RU2141483C1 (en) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Peptide derivatives or their pharmaceutically acceptable salts, method of their synthesis, use and pharmaceutical composition

Also Published As

Publication number Publication date
GB2437429A (en) 2007-10-24

Similar Documents

Publication Publication Date Title
PL2192109T3 (en) Bicyclic -amino acid derivative
HK1149756A1 (en) Isoxazolo-pyridine derivatives
IL205753A0 (en) Isoxazolo-pyridazine derivatives
IL201611A0 (en) Lipoic acid derivatives
HRP20130004T8 (en) 4-substituted phenoxyphenylacetic acid derivatives
IL202020A0 (en) Spiroindolinone derivatives
IL202830A0 (en) Indazolamide derivatives
IL205755A0 (en) Isoxazolo-pyrazine derivatives
IL200618A0 (en) Aza-pyridopyrimidinone derivatives
TWI348908B (en) Imidazolidinone derivatives
PL2225238T3 (en) Derivatives of 6,7-dihydro-5h-imidazoý1,2- ¨imidazole-3- carboxylic acid amides
HK1226051A1 (en) 14-hydroxy-docosahexaenoic acid compounds
IL205148A0 (en) Novel imidazole derivatives
IL202667A0 (en) Isoxazole-imidazole derivatives
PL2245028T3 (en) 5-aminocyclylmethyl-oxazolidin-2-one derivatives
PL2213669T3 (en) Crystalline imidazol-5-carboxylic acid derivate
EP2133347A4 (en) 1-biarylazetidinone derivatives
IL206524A0 (en) 4-dimethylminobutyric acid derivatives
IL205149A0 (en) Novel imidazole derivatives
HK1141009A1 (en) Sulfonyl-quinoline derivatives
IL202159A0 (en) Piperidine-amide derivatives
GB0713189D0 (en) Amino acid derivatives
HK1146276A1 (en) Thiadiazinone derivatives
GB0715712D0 (en) Amino acid derivatives
GB0711234D0 (en) Urocanic acid derivatives

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)